Zurich Cantonal Bank
CNTA

Zurich Cantonal Bank’s Centessa Pharmaceuticals CNTA Stock Holding History

Zurich Cantonal Bank’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$40 – 2559
2026
Q1 		$40 Buy
+1
New +$26 ﹤0.01% 2531
2025
Q4 		– Sell
-481
Closed -$12.2K – 2773
2025
Q3 		$11.7K Sell
481
-201
-29% -$3.57K ﹤0.01% 2493
2025
Q2 		$8.96K Sell
682
-73
-10% -$925 ﹤0.01% 2520
2025
Q1 		$10.9K Sell
755
-1,058
-58% -$17.3K ﹤0.01% 2590
2024
Q4 		$30.4K Sell
1,813
-386
-18% -$6.39K ﹤0.01% 2582
2024
Q3 		$35.2K Sell
2,199
-35
-2% -$429 ﹤0.01% 2581
2024
Q2 		$20.2K Sell
2,234
-33
-1% -$313 ﹤0.01% 2590
2024
Q1 		$25.6K Buy
+2,267
New +$21.5K ﹤0.01% 2615

Zurich Cantonal Bank's CNTA Position: Q2 2026 in Review

Zurich Cantonal Bank sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 1 share — an estimated $40 sold.

Zurich Cantonal Bank first reported a position in CNTA in Q1 2024 and held it in 8 quarters. The position peaked at $35.2K in Q3 2024. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

  • Zurich Cantonal Bank reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Zurich Cantonal Bank sold 1 Centessa Pharmaceuticals share in Q2 2026, an estimated $40.
  • Zurich Cantonal Bank first reported a position in Centessa Pharmaceuticals in Q1 2024 and held it in 8 quarters.
  • Zurich Cantonal Bank's Centessa Pharmaceuticals position peaked at $35.2K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.